Recent studies suggest that many cases of dry eye (DE) have evidence of neuropathic pain that arises from chronic disorders of, as well as acute damage to, the corneal nerves.^[@i1552-5783-57-13-5285-b01][@i1552-5783-57-13-5285-b02][@i1552-5783-57-13-5285-b03][@i1552-5783-57-13-5285-b04]--[@i1552-5783-57-13-5285-b05]^ Dry eye symptoms such as burning, dryness, foreign body sensations, and decreased vision have been reported following ocular surgical procedures that involve the cornea. These include photorefractive keratectomy, laser in situ keratomileusis,^[@i1552-5783-57-13-5285-b06]^ corneal cross-linking for keratoconus,^[@i1552-5783-57-13-5285-b07]^ cataract surgery,^[@i1552-5783-57-13-5285-b08]^ lamellar keratoplasty,^[@i1552-5783-57-13-5285-b09]^ and others. Though these symptoms are typically transient, the chronic symptoms are severe and debilitating in some patients who report classic characteristics of neuropathic pain, including persistent and severe allodynia, hyperalgesia, and dysaesthesia,^[@i1552-5783-57-13-5285-b03]^ similar to postoperative nonocular surgical procedures.^[@i1552-5783-57-13-5285-b10]^

These sensations can extend beyond the cornea. We have observed patients whose eye pain is accompanied by pain in other areas of the receptive fields of the trigeminal nerve, including the orbits, head, ears, face, jaw, and teeth.^[@i1552-5783-57-13-5285-b04]^ Furthermore, they report painful photophobia that in some patients represents the dominant disabling symptom. Here, we make the case for oculofacial pain as a trigeminal pain that shares many features with the orofacial pain spectrum. Just as orofacial pain is by definition pain felt in the oral cavity and face, oculofacial pain would similarly be defined as pain experienced in the eyes and orbits primarily but may extend to the rest of the face.

As a model of oculofacial pain, consider the often comorbid conditions of DE and migraine/headache.^[@i1552-5783-57-13-5285-b11]^ Headache and DE share certain pathophysiological features within the trigeminal system. Moreover, sensory changes are multidimensional and can include photophobia. This model suggests how chronic corneal pain may contribute to increased severity of other components of oculofacial pain. For example, the neuropathic processes underlying DE can lead to increased afferent inputs to the trigeminal system, including neurons in the trigeminal ganglion, second-order neurons in the trigeminal brainstem, and third-order neurons in the thalamus. Such changes can provide a barrage of activity in neurons already affected by the sensory processes of trigeminovascular activation in migraine.^[@i1552-5783-57-13-5285-b12]^

Similarly, changes in corneal nerve morphology have been associated with more severe photophobia in patients without migraine.^[@i1552-5783-57-13-5285-b13]^ Studies in animals have shown that bright light can enhance trigeminal reflex blinks and induce trigeminal sensitization.^[@i1552-5783-57-13-5285-b14],[@i1552-5783-57-13-5285-b15]^ In a patient with photophobia, multiple levels of the trigeminal pathways were shown to be sensitized to light.^[@i1552-5783-57-13-5285-b16]^ The representation of the cornea within the primary somatosensory cortex^[@i1552-5783-57-13-5285-b17]^ and other brain regions may provide a basis for the central sensitization of pain. These initial localized changes may induce central sensitization across multiple brain structures, thereby resulting in chronic pain, and ultimately recruiting sensory and emotional areas. Primary damage to corneal nerve endings may exacerbate preexisting underlying diseases (e.g., migraine). Alternatively, while these changes are considered a primary manifestation of a disease, they may also contribute to other painful manifestations in the orofacial region.

Referred pain experienced in regions other than its primary source is a well-described phenomenon in somatic pain,^[@i1552-5783-57-13-5285-b18]^ and orofacial referred pain has been described with odontogenic pains.^[@i1552-5783-57-13-5285-b19]^ Trigeminal traumatic neuropathic pain following nerve damage from oral surgery has been correlated with abnormal corneal reflexes,^[@i1552-5783-57-13-5285-b18]^ suggesting complex interactions across multiple levels of the trigeminal system. Similarly, photophobia is also increased in migraineurs during experimental thermal or painful stimulation of skin.^[@i1552-5783-57-13-5285-b20]^

The mechanisms underlying referred pain include alterations in central nervous system regions such as the trigeminal nucleus^[@i1552-5783-57-13-5285-b21]^ and thalamus.^[@i1552-5783-57-13-5285-b22]^ In a rat model with unilateral nerve damage, uninjured nerves may contribute to altered patterns of pain inside and outside of the affected territories.^[@i1552-5783-57-13-5285-b23]^ In human studies using a capsaicin model, cross-innervated territories develop mechanical allodynia through the process of central sensitization.^[@i1552-5783-57-13-5285-b24]^ The convergence of neurons that innervate all the trigeminal nerve territories to the trigeminal nucleus is a basis for referred pain (Fig.).^[@i1552-5783-57-13-5285-b25],[@i1552-5783-57-13-5285-b26]^ How do these observations affect the presentation of oculofacial pain? Previous reports have defined what may be referred pain from corneal structures that have been labeled as "factious disease."^[@i1552-5783-57-13-5285-b27]^ The reverse is also worth noting: Corneal pain is diminished in cluster headache,^[@i1552-5783-57-13-5285-b28]^ presumably through descending inhibitory controls.

We propose the existence of an overlooked trigeminal pain that we have named "oculofacial pain" and suggest that it represents referred pain, perhaps arising from a malfunctioning trigeminal brainstem.^[@i1552-5783-57-13-5285-b28]^ In our opinion, patients with very symptomatic DE may suffer from a highly disabling pain disease that had been underappreciated because of its characteristic and deceptive lack of appropriate causal signs. On the other hand, some DE patients with significant corneal epithelial disease have few if any symptoms, perhaps due to degeneration of corneal nociceptors. We further argue that because of the severity of symptoms and misleadingly benign appearance of these eyes, the manifestations of this disease have been overlooked in the clinic. Focused efforts to further define oculofacial pain would increase awareness of this disease and improve efforts to understand its underlying mechanisms, which could lead to the development of effective treatments.

![Trigeminal convergence pathway for oculofacial pain. Temperature, mechanosensitive, and polymodal nociceptors transduce noxious input from acute injury or inflammation into neural signals.^[@i1552-5783-57-13-5285-b29]^ Innervation of the cornea supplies afferents through branches of the ophthalmic division of the trigeminal nerve. These first-order neurons converge with afferent inputs from the other two divisions of the trigeminal nerve (maxillary and mandibular) and are somatotopically organized within the trigeminal ganglion. The neuronal bodies of the trigeminal nerve, located in the ganglion, have central projections that synapse in the trigeminal nucleus. Second-order neurons cross over in their ascending pathway (trigeminothalamic tract) to nuclei within the thalamus (e.g., ventroposteriormedial thalamus). From here, third-order neurons project to the primary somatosensory cortex where the cornea is functionally represented. The boxes below show referred pain (*left*) to the cornea from orofacial somatic and visceral structures and (*right*) to orofacial viscera from the cornea and skin. Such convergence may occur within the central nervous system, potentially involving the trigeminal nucleus and/or thalamus.](i1552-5783-57-13-5285-f01){#i1552-5783-57-13-5285-f01}
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